ArticleFunctional & integrative genomics2023

Transcriptome- and metabolome-based candidate mechanism of BCR-ABL-independent resistance to olverembatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Zhao Yin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.